Analysts: Ebos paid nearly twice as much as usual for HPS
Ebos' expensive HPS purchase was a defensive move
Hot Topic
ELECTIONS
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Ebos is paying nearly twice as much for hospital pharmacy company HPS than it usually pays for the businesses it buys, analysts say.
It paid $A154 million for HPS and said it would increase 2018 operating earnings by at least 5%.
The consensus among analysts before the purchase was that Ebos’
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Jenny Ruth
Mon, 29 May 2017
Mon, 29 May 2017
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Analysts: Ebos paid nearly twice as much as usual for HPS
67333